Ειδήσεις: HC WAINWRIGHT | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

01/04 10:41 defenseworld.net

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Rating of “Moderate Buy” by Analysts

AnaptysBio Moderate Buy Analyst Ratings Price Target Pipeline Clinical Milestones

01/04 10:16 defenseworld.net

Bicara Therapeutics (NASDAQ:BCAX) Price Target Raised to $42.00 at HC Wainwright

Bicara Therapeutics price target HC Wainwright analyst ratings Citigroup Weiss Ratings

01/04 09:44 defenseworld.net

Aktis Oncology (NASDAQ:AKTS) Given New $33.00 Price Target at HC Wainwright

Aktis Oncology price target HC Wainwright TD Cowen Bank of America Wall Street Zen

01/04 08:00 defenseworld.net

Q1 Earnings Estimate for Worksport Issued By HC Wainwright

Worksport HC Wainwright earnings estimate Q1 2026 negative EPS target price

30/03 11:00 defenseworld.net

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update

Adlai Nortye ANL short interest days-to-cover analyst rating Weiss Ratings

30/03 08:28 defenseworld.net

Equities Analysts Offer Predictions for DNLI FY2027 Earnings

Denali Therapeutics HC Wainwright FY2027 EPS Buy rating $42 price target equity research

30/03 08:10 defenseworld.net

HC Wainwright Forecasts Palisade Bio Q1 Earnings

Palisade Bio HC Wainwright Q1 earnings EPS forecast Buy rating price objective

30/03 08:10 defenseworld.net

What is HC Wainwright’s Estimate for DBVT Q1 Earnings?

HC Wainwright DBV Technologies Q1 2026 EPS forecast negative earnings FY2030 outlook

30/03 08:10 defenseworld.net

Equities Analysts Set Expectations for Neurogene Q1 Earnings

Neurogene HC Wainwright EPS forecast Buy rating target price Q1 earnings

30/03 08:10 defenseworld.net

Equities Analysts Set Expectations for Neurogene Q1 Earnings

Neurogene HC Wainwright EPS forecast Buy rating target price Q1 earnings

Loading...